Send to

Choose Destination
See comment in PubMed Commons below
Ann N Y Acad Sci. 2011 Sep;1232:114-39. doi: 10.1111/j.1749-6632.2011.06048.x.

Barrett's esophagus: proton pump inhibitors and chemoprevention II.

Author information

Department of Medicine, Temple University, Philadelphia, Pennsylvania, USA.

Erratum in

  • Ann N Y Acad Sci. 2011 Dec;1239:162. Tenca, Andrea [added].


The following on proton pump inhibitors (PPIs) and chemoprevention in relation to Barrett's esophagus includes commentaries on 48-h pH monitoring, pH-impedence, bile acid testing, dyspepsia, long/short segment Barrett's esophagus, nonerosive reflux disease (NERD), functional heartburn, dual-release delivery PPIs, immediate-release PPIs, long-term PPI use, prokinetic agents, obesity, baclofen, nocturnal acid breakthrough, nonsteroidal anti-inflammatory drugs (NSAIDs), and new PPIs.

[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wiley
    Loading ...
    Support Center